Continuous Precision Medicine (CPM) was founded with the core mission of combating opioid addiction through personalized medication management. The company's vision is to provide innovative and effective solutions to one of the most costly and emotionally damaging healthcare issues. CPM offers tools designed to manage medication in a controlled and personalized manner, focusing on preventative care to achieve definitive results. Their market focus is primarily on healthcare providers and patients dealing with opioid dependency.
Notable affiliated people and investors include experts in healthcare technology and addiction treatment, though specific names are not provided. Key achievements of CPM include the development of advanced tools that have shown promise in reducing opioid misuse and improving patient outcomes. The overall impact of CPM has been significant in the realm of opioid addiction, providing both patients and healthcare providers with essential resources to manage and prevent abuse effectively.